These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8723033)

  • 1. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
    Groopman JD; Wang JS; Scholl P
    Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metabolism and viruses in aflatoxin-induced liver cancer.
    Groopman JD; Kensler TW
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):131-7. PubMed ID: 15967201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biomarkers for aflatoxins and their application to human cancer prevention.
    Groopman JD; Wogan GN; Roebuck BD; Kensler TW
    Cancer Res; 1994 Apr; 54(7 Suppl):1907s-1911s. PubMed ID: 8137310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure biomarkers in chemoprevention studies of liver cancer.
    Wild CP; Turner PC
    IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biomarkers for aflatoxins and their application to human liver cancer.
    Scholl P; Musser SM; Kensler TW; Groopman JD
    Pharmacogenetics; 1995; 5 Spec No():S171-6. PubMed ID: 7581490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.
    Groopman JD; Johnson D; Kensler TW
    Cancer Biomark; 2005; 1(1):5-14. PubMed ID: 17192028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: lack of association.
    Hsieh DP; Atkinson DN
    Food Addit Contam; 1995; 12(3):421-4. PubMed ID: 7664937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
    Kensler TW; Groopman JD
    J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models.
    Groopman JD; Roebuck BD; Kensler TW
    Prog Clin Biol Res; 1992; 374():139-55. PubMed ID: 1320272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in environmental carcinogenesis research: striving for a new momentum.
    Kyrtopoulos SA
    Toxicol Lett; 2006 Mar; 162(1):3-15. PubMed ID: 16321483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
    Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of biomarkers in evaluating human health concerns from fungal contaminants in food.
    Turner PC; Flannery B; Isitt C; Ali M; Pestka J
    Nutr Res Rev; 2012 Jun; 25(1):162-79. PubMed ID: 22651937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
    Groopman JD; Scholl P; Wang JS
    Prog Clin Biol Res; 1996; 395():211-22. PubMed ID: 8895991
    [No Abstract]   [Full Text] [Related]  

  • 16. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
    Wogan GN
    Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological relevance of adduct detection to the chemoprevention of cancer.
    Sharma RA; Farmer PB
    Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
    Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.